Trial Profile
A fixed sequence, two period crossover study, in healthy volunteer to evaluate the drug interaction between tenofovir alafenamide, emtricitabine and ritonavir boosted atazanavir or darunavir or lopinavir or dolutegravir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Atazanavir/ritonavir; Darunavir/ritonavir; Dolutegravir; Emtricitabine; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 16 Feb 2015 New trial record